Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA] - N0000194094

Name: Table of NDC products with tropomyosin receptor tyrosine kinase a inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000194094
Pharmacologic Name	Tropomyosin Receptor Tyrosine Kinase A Inhibitors
Pharmacologic Uses	kinase inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Tropomyosin Receptor Tyrosine Kinase A Inhibitors

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0003-4040	Augtyro	Non-Proprietary Name: Repotrectinib	Capsule	Oral	E.r. Squibb & Sons, L.l.c.	ACTIVE
	0003-4160	Augtyro	Non-Proprietary Name: Repotrectinib	Capsule	Oral	E.r. Squibb & Sons, L.l.c.	ACTIVE